A detailed history of Creative Planning transactions in Pulmonx Corp stock. As of the latest transaction made, Creative Planning holds 17,057 shares of LUNG stock, worth $108,141. This represents 0.0% of its overall portfolio holdings.

Number of Shares
17,057
Previous 16,634 2.54%
Holding current value
$108,141
Previous $212,000 25.47%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024

BUY
$8.71 - $14.65 $3,684 - $6,196
423 Added 2.54%
17,057 $158,000
Q4 2023

Feb 14, 2024

BUY
$7.89 - $13.14 $11,779 - $19,618
1,493 Added 9.86%
16,634 $212,000
Q3 2023

Nov 16, 2023

SELL
$9.88 - $14.0 $3,201 - $4,536
-324 Reduced 2.1%
15,141 $156,000
Q2 2023

Jul 21, 2023

BUY
$10.78 - $13.65 $2,651 - $3,357
246 Added 1.62%
15,465 $202,000
Q1 2023

May 15, 2023

BUY
$7.49 - $12.54 $7,130 - $11,938
952 Added 6.67%
15,219 $170,000
Q4 2022

Feb 10, 2023

BUY
$4.92 - $17.35 $70,193 - $247,532
14,267 New
14,267 $120,000

Others Institutions Holding LUNG

About Pulmonx Corp


  • Ticker LUNG
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 37,268,400
  • Market Cap $236M
  • Description
  • Pulmonx Corporation, a medical technology company, provides minimally invasive devices for the treatment of chronic obstructive pulmonary diseases. It offers Zephyr Endobronchial Valve, a solution for the treatment of bronchoscopic in adult patients with hyperinflation associated with severe emphysema; and Chartis Pulmonary Assessment System, a ...
More about LUNG
Track This Portfolio

Track Creative Planning Portfolio

Follow Creative Planning and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Creative Planning, based on Form 13F filings with the SEC.

News

Stay updated on Creative Planning with notifications on news.